Voltar
Artigo Acesso aberto Produção Nacional
BIBTEX RIS

Findings in magnetic resonance spectroscopy in patients with Autism spectrum disorder

2023; Volume: 17; Issue: 3 Linguagem: Inglês

10.30574/gscarr.2023.17.3.0453

ISSN

2582-4597

Autores

Isaac Azevedo Tenorio, Lara A. Brandão, Aderbal Sabrá Filho, Selma Sabrá, Thiago Luiz Bandeira, Isabela Mansur Bandeira, Ana Maria E. Dias dos Santos, N. Manuel, Paula Pessanha Silva Mitre, Camila Marques Rebello, Bruno De Brito Braga, Luiz Werber Bandeira, Aderbal Sabrá,

Tópico(s)

Congenital heart defects research

Resumo

Background: Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition that has been the subject of extensive research, including studies using magnetic resonance imaging (MRI) to explore brain metabolites as potential biomarkers. Methods: The objective of our study was to identify brain metabolites using magnetic resonance and proton spectroscopy that could serve as potential markers of ASD (Autism Spectrum Disorder). Results: Magnetic resonance imaging did not reveal any brain morphological changes in ASD patients. However, the patients with ASD exhibited an elevated glutamate peak in 100% of cases. Conclusions: Magnetic resonance imaging combined with cerebellar spectroscopy is an emerging tool for the diagnosis and management of autism. This approach shows promise in enhancing both the diagnosis and treatment of ASD.

Referência(s)